|
- Biovac – Science of Protecting Life
Biovac is a bio-pharmaceutical company based in Cape Town that is the result of a partnership formed with the South African government in 2003 to establish local vaccine manufacturing capability for the provision of vaccines for national health management and security
- Biovac
Biovac Nepal Private Limited is a vaccine research, development and manufacturing company based in Nepal It uses the latest technologies to understand disease burden, dynamics, evaluate novel vaccine targets, and manufacture vaccines that have high efficacy and are cost effective
- BioVac Direct Suction Device | STERIS
Designed to suction hard-to-remove, viscous materials, the BioVac endoscopic suction device bypasses the scope control head, alleviating intraprocedural clogging of the scope which may help physicians to locate and treat the bleeding site more quickly
- Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture . . .
Biovac will obtain drug substance from facilities in Europe, and manufacturing of finished doses will commence in 2022 At full operational capacity, the annual production will exceed 100 million finished doses annually
- Biovac A - vaccinebox. com
Biovac A is a freeze dried live attenuated vaccine indicated for prevention of disease caused by Hepatitis A Virus (HAV) in persons of age 1 year and older It can be used for primary immunization Only one dose of Biovac A staring at 12 months through 23 months of age
- Autogenous vaccines - USA
Cevac Biovac in France, and Ceva Lenexa in the USA are R D and production centers with over 20 years’ experience in autogenous vaccine development and distribution
- BioVac Inc.
BioVac supplies products in the field of Life Science, Biological Research and Vacuum applications
- Media – Biovac
PFIZER, SANOFI, TO BOOST SOUTH AFRICAN BIOVAC’S VACCINE OUTPUT… South Africa’s Biovac Institute will start local production of Sanofi’s Hexaxim vaccine next year and Pfizer’s anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market
|
|
|